|Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!
KUFA has moved!
Our NYC address is
104 West 40th Street, Suite 500
New York, NY 10018
Our HQ office is
63 West Main Street, Suite G
Freehold, NJ 07728
Chronic kidney disease (CKD) is a worldwide public health problem with adverse outcomes of kidney failure and premature death. CKD affects approximately 195 million women worldwide and it is currently the 8th leading cause of death in women, with close to 600,000 deaths each year.
A letter from the parent of one of KUFA's scholarship recipients...
Just a status update I knew all of you and KUFA would appreciate hearing about.
Brittany just graduated in May with her Master's Degree from Boston University School of Public Health in two areas of concentration:
2. Health Policy and Management
She was home (in Fl) with family for the summer while she began the search for work. This past weekend I helped her move in to her apartment in Cambridge, MA. She just landed her first job and I think you all would be most happy to know what it is and where...
Beginning next week (9-17-12), Brittany will be the new Clinical Trials Coordinator at Boston Children's Hospital Renal Transplantation Division working with Harvard clinical trial studies led by Dr. William Harmon, Director of Pediatric Nephrology at BCH and Professor of Pediatrics, Harvard Medical School. His main research interests deal with Pathophysiology and treatment of end-stage renal disease (ESRD) in children, Clinical Trials, Novel Immuno-suppression. Tolerance induction.
Join us in recognizing the important contributions
of Social Workers.
Cure Glomerulonephropathy Network
We still have a lot to learn about why people develop glomerular disease and what the best medicines are to treat these diseases. This network brings a large group of patient information and laboratory specimens together to speed up and improve health research.
For more information, click here.